Table 1 Characteristics at baseline of VACS Patients enrolled in survey sample and of those with clinically confirmed community acquired pneumonia (confirmed-CAP) within the sample
VACS Survey Sample | With Confirmed-CAP | |||||||
|---|---|---|---|---|---|---|---|---|
Total | PWH | Uninfected | P | Total | PWH | Uninfected | P | |
Demographics | 6824 | 3410 | 3414 | – | 397 | 321 | 76 | – |
Mean age in years (SD) | 49.8 (9.4) | 49.1 (8.8) | 50.4 (10.0) | < 0.001 | 53.3 | 52.2 | 57.8 | < 0.001 |
Male Gender | 95% | 97% | 92% | < 0.001 | 97% | 98% | 95% | 0.1 |
Non-white race | 79% | 81% | 76% | < 0.001 | 86% | 89% | 72% | 0.002 |
Behaviors | ||||||||
Tobacco use ever | 75% | 77% | 72% | < 0.001 | 86% | 86% | 88% | 0.3 |
Hazardous alcohol use | 27% | 26% | 28% | 0.009 | 29% | 29% | 28% | 0.8 |
IV drug use ever | 25% | 33% | 16% | < 0.001 | 41% | 47% | 16% | < 0.001 |
Comorbidities | ||||||||
Diabetes mellitus | 33% | 28% | 38% | < 0.001 | 44% | 41% | 54% | .04 |
CKD | 12% | 13% | 11% | .07 | 24% | 22% | 28% | 0.4 |
COPD | 5% | 5% | 5% | .7 | 10% | 9% | 14% | 0.2 |
HCV | 41% | 53% | 28% | < 0.001 | 58% | 65% | 28% | < 0.001 |
HIV Parameters | ||||||||
CD4 ≥ 200 cells/μL | – | 76% | – | – | – | 64% | – | – |
On antiretroviral treatment | – | 72% | – | – | – | 68% | – | – |
VL ≤500 RNA copies/mL | – | 50% | – | – | – | 40% | – | – |
EHR CAP Codes | ||||||||
Any Inpatient CAP ICD-9 code, n (%) | 549 (8) | 433 (13) | 116 (4) | < 0.001 | – | – | – | – |
Confirmed-CAP by chart review, n (%) | 397 (6) | 321 (9) | 76 (2) | < 0.001 | – | – | – | – |